Abstract Hepatitis B Surface Antigen (HBsAg) seroclearance is the highest treatment goal recommended by the current guidelines for hepatitis B. Levels of antibodies to HBsAg (anti-HBs) are strongly associated with HBsAg recurrence, but hepatitis B vaccination may increase the anti-HBs seroconversion rate and reduce recurrence. We conducted a retrospective clinical study to ascertain the effect of this vaccination on the seroconversion rate and levels of protective anti-HBs after HBsAg. In this retrospective study, we distributed a questionnaire through an online survey platform to collect information related to hepatitis B vaccination in patients with functional cure of hepatitis B with Interferon-α (IFNα) therapy. We enrolled 320 patients who achieved functional cure from IFNα therapy. Of these, 219 patients had received hepatitis B vaccination according to their personal preference and drug accessibility after HBsAg seroclearance, whereas the remaining 101 patients did not receive hepatitis B vaccination. The anti-HBs seroconversion rate of 78.1% in the vaccinated group was significantly greater than that in the unvaccinated group (41.6%) (p < 0.001). Stratified comparisons with anti-HBs of ≥ 100 IU/L and ≥ 300 IU/L showed that both proportions in the vaccinated group were greater than those in the unvaccinated group (71.2% vs. 32.7% and 56.2% vs. 17.8%, respectively, all p-values < 0.001). Logistic regression analysis showed that the odds ratio of vaccination was 4.427, which was the strongest influencing factor for anti-HBs, reaching 100 IU/L or higher. Hepatitis B vaccination in patients after HBsAg seroclearance not only increased the anti-HBs seroconversion rate but also significantly increased antibody levels, with good safety, indicating the clinical value of vaccine therapy for patients with functional cure.

Abstract To investigate the imaging features and clinic value of magnetic resonance imaging (MRI) and computed tomography (CT) in the diagnosis of clear cell renal cell carcinoma (ccRCC). 139 RCC patients underwent MRI and CT examination before surgery, and the sensitivity, specificity, accuracy, positive and negative predictive values of MRI and CT in diagnosing ccRCC were analyzed and compared. There were 93 true-positive, 11 false-positive, 11 false-negative and 24 true-negative in MRI screening with sensitivity, specificity, accuracy, positive predictive value and negative predictive value of 89.42%, 68.57%, 84.17%, 89.42% and 68.57% respectively. Whereas there were 72 true-positive, 4 false-positive, 32 false-negative and 31 true-negative in CT screening with the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of 69.23%, 88.57%, 74.10%, 94.74% and 49.21% respectively. The sensitivity and negative predictive value of MRI were better than those of CT, while the specificity of CT was better than that of MRI. MRI and CT have respective advantages in the diagnosis of ccRCC. The sensitivity and negative predictive value of MRI are superior to those of CT, while the specificity of CT is superior to that of MRI. Clinically, different examinations are selected according to different situations.

摘要 目的 评价中国传染病自动预警与响应系统在探测手足口疾病（HFM）爆发方面的表现。 方法 我们利用2008年5月1日和2010年4月30日之间以及2010年5月1日和2012年4月30日之间（即自动预警与响应系统将手足口病纳入之前和之后）报告的病例估算了手足口病病爆发的规模、持续时间...

Résumé Objectif Évaluer les résultats du système automatisé d'alerte et d'action pour les maladies infectieuses de la Chine en matière de détection des épidémies de maladie des mains, pieds et bouche (MMPB). Méthodes Nous avons estimé la taille, la durée et le retard du signalement des épidémies de MMPB à partir des cas notifiés entre le 1er mai 2008 et le 30 avril 2010 et entre le 1er mai 2010 et le 30 avril 2012, c'est-à-dire avant et après l'intégration de la MMPB dans le système automatisé d'alerte et d'action. La sensibilité, la spécificité et la rapidité de la détection des aberrations dans l'incidence des épidémies de MMPB ont été estimées en comparant les détections automatisé...

Резюме Цель Оценить эффективность автоматизированной системы оповещения и реагирования в Китае, используемой для обнаружения вспышек вирусной пузырчатк...

Objective To evaluate the performance of China’s infectious disease automated alert and response system in the detection of outbreaks of hand, foot and mouth (HFM) disease. Methods We estimated size, duration and delay in reporting HFM disease outbreaks from cases notified between 1 May 2008 and 30 April 2010 and between 1 May 2010 and 30 April 2012, before and after automatic alert and response included HFM disease. Sensitivity, specificity and timeliness of detection of aberrations in the incidence of HFM disease outbreaks were estimated by comparing automated detections to observations of public health staff. Findings The alert and response system recorded 106 005 aberrations in the incidence of HFM disease between 1 May 2010 and 30 April 2012 – a mean of 5.6 aberrations per 100 days in each county that reported HFM disease. The response system had a sensitivity of 92.7% and a specificity of 95.0%. The mean delay between the reporting of the first case of an outbreak and detection of that outbreak by the response system was 2.1 days. Between the first and second study periods, the mean size of an HFM disease outbreak decreased from 19.4 to 15.8 cases and the mean interval between the onset and initial reporting of such an outbreak to the public health emergency reporting system decreased from 10.0 to 9.1 days. Conclusion The automated alert and response system shows good sensitivity in the detection of HFM disease outbreaks and appears to be relatively rapid. Continued use of this system should allow more effective prevention and limitation of such outbreaks in China.

ملخص الغرض تقييم أداء نظام الإنذار والاستجابة الآلي للأمراض المعدية في اكتشاف فاشيات مرض اليد والقدم والفم في الصين. الطريقة قمنا بتقدير الحجم والمدة وال...

Resumen Objetivo Evaluar el rendimiento del sistema de alerta y respuesta automática a enfermedades infecciosas de China en la detección de brotes de la enfermedad boca-mano-pie (EBMP). Métodos Calculamos la magnitud, la duración y la demora en la notificación de brotes de la enfermedad BMP a partir de casos notificados entre el 1 de mayo de 2008 y el 30 de abril de 2010, y entre el 1 de mayo de 2010 y el 30 de abril 2012, antes y después de que el sistema de alerta y respuesta automáticas incluyera la enfermedad BMP. Se estimó la sensibilidad, especificidad y oportunidad de la detección de aberraciones en la incidencia de los brotes de enfermedad BMP mediante la comparación de las detecciones automáticas con las observaciones del personal de salud pública. Resultados El sistema de alerta y respuesta registró 106 005 aberraciones en la incidencia de la EBMP entre el 1 de mayo de 2010 y el 30 de abril de 2012 - una media de 5,6 aberraciones por cada 100 días en cada condado que notificó dicha enfermedad. El sistema de respuesta tuvo una sensibilidad del 92,7 % y una especificidad del 95,0 %. La demora media entre la notificación del primer caso de un brote y la detección de ese brote por el sistema de respuesta fue de 2,1 días. Entre el primer y el segundo período de estudio, las dimensiones medias de un brote de EBMP disminuyeron de 19,4 a 15,8 casos, y el intervalo medio entre el comienzo de un brote y el primer informe en el sistema de notificación de emergencia de salud pública se redujo de 10,0 a 9,1 días. Conclusión El sistema de alerta y respuesta automática muestra una buena sensibilidad en la detección de los brotes de EBMP y parece ser relativamente rápido. El uso continuado de este sistema debería permitir una prevención y limitación más eficaces de dichos brotes en China.